Kidney stones are one of the most common urological diseases worldwide and represent a growing burden on healthcare systems. Traditional diagnostic procedures and therapeutic approaches, from imaging and drug-based stone dissolution to invasive surgical methods, are fraught with limitations. Nanomedicine opens up new perspectives here: Nanomaterials enable more precise early detection, improve imaging, have antioxidant and antibacterial effects, transport drugs in a more targeted manner and can even control biofilm-associated infections. The following article presents the latest advances in this field and discusses the clinical relevance for nephrologists.
You May Also Like
- Case study
Autosomal recessive polycystic kidney disease: atypical phenotype
- Current evidence, risk classes and new counseling options
Hormonal contraception and cardiovascular risk
- Acute otitis media: self-limiting course vs. "red flags"
In which cases are antibiotics necessary?
- Prurigo nodularis: evidence-based treatment
Targeted therapy options on the rise
- MACE risk, heart failure incidence and all-cause mortality
Metabolic syndrome as a cardiovascular risk factor
- Glaucoma in old age: slowing down progression
IOP lowering is currently the only evidence-based treatment
- Vector-borne infections with skin manifestations
Arboviruses and leishmaniasis in Europe
- Multimorbidity and functional capacity in old age